Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GROWTH AND TOLERANCE OF A NEW INFANT FORMULA USING AN EXTENSIVELY HYDROLYZED CASEIN-BASED PROTEIN (eHCF)

NCT07513506 is registered in ClinicalTrials.gov with Mead Johnson Nutrition as lead sponsor.

NCT NCT07513506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07513506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GROWTH AND TOLERANCE OF A NEW INFANT FORMULA USING AN EXTENSIVELY HYDROLYZED CASEIN-BASED PROTEIN (eHCF)
Lead sponsor
Mead Johnson Nutrition
Phase
Not applicable
Overall status
Not yet recruiting
Start date
April 3, 2026
Completion date
May 1, 2027
Enrollment
214 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

growth